Table 2.
C. difficile antigen and toxin detection and number of tests performed before and during the COVID-19 pandemic.
| Month | Control Group 2018–2019 | COVID-19 Group 2020–2021 | ||||||
|---|---|---|---|---|---|---|---|---|
| No. of Admitted Patients | No. (%) of CD-Tested Patients | No. (%) of CD-Positive Cases among Admitted Patients | No. (%) of CD Toxin-Positive Cases among Admitted Patients | No. of Admitted Patients | No. (%) of CD-Tested Patients | No. (%) of CD-Positive Cases among Admitted Patients | No. (%) of CD Toxin-Positive Cases among Admitted Patients | |
| November | 23 | 2 (8.7) | 0 | 0 | 55 | 8 (14.5) | 3 (5.5) | 2 (3.6) |
| December | 28 | 2 (7.14) | 0 | 0 | 56 | 7 (12.5) | 5 (8.9) | 3 (5.4) |
| January | 30 | 4 (13.3) | 1 (3.3) | 1 (3.3) | 64 | 20 (31.2) | 15 (23.4) | 9 (14.1) |
| February | 35 | 5 (14.3) | 1 (2.9) | 1 (2.9) | 40 | 25 (62.5) | 16 (40) | 10 (25) |
| March | 28 | 3 (10.7) | 1 (3.6) | 0 | 84 | 71 (84.5) | 40 (47.6) | 13 (15.5) |
| April | 22 | 2 (9.1) | 2 (9.1) | 1 (4.5) | 52 | 44 (84.6) | 16 (30.8) | 7 (13.5) |
| May | 23 | 2 (8.7) | 0 | 0 | 21 | 17 (81) | 7 (33.3) | 2 (9.5) |
| Total | 189 | 20 (10.6) | 5 (2.6) | 3 (1.6) | 372 | 192 (51.6) | 102 (27.4) | 46 (12.4) |
CD: Clostridioides difficile.